Acinar Cell Carcinoma
Adenocarcinoma in Situ
Adenoid Cystic Carcinoma
Clear Cell Adenocarcinoma
Extramammary Paget Disease
Intraductal Noninfiltrating Carcinoma
Islet Cell Carcinoma
Ovine Pulmonary Adenomatosis
Renal Cell Carcinoma
Signet Ring Cell Carcinoma
Skin Appendage Carcinoma
Aldesleukin is classified as a Lymphocyte Growth Factor. Aldesleukin is more commonly known as the brand Proleukin.
Alendronate, an ingredient in the more commonly known brands Binosto, Fosamax and Fosamax Plus D, may be used to treat Adenocarcinoma.
Chlorambucil is classified as an Alkylating Drug. Chlorambucil is more commonly known as the brand Leukeran.
Dacarbazine is classified as an Alkylating Drug.
Dactinomycin is classified as an Actinomycin. Dactinomycin is more commonly known as the brand Cosmegen.
Gemcitabine is classified as a Nucleoside Metabolic Inhibitor. Gemcitabine is more commonly known as the brand Gemzar.
Hydroxyurea is classified as an Antimetabolite. Hydroxyurea, more commonly known as the brands Droxia and Hydrea, may be used to treat Adenocarcinoma.
Interferon Alfa-2A is classified as an Interferon alpha.
Interferon Alfa-2B is classified as an Interferon alpha. Interferon Alfa-2B is more commonly known as the brand Intron A.